<DOC>
	<DOCNO>NCT02683226</DOCNO>
	<brief_summary>The purpose study determine whether dual treatment metformin alogliptin effective treatment metformin , alogliptin pioglitazone treatment obese woman polycystic ovary syndrome ( PCOS ) regard insulin resistance beta cell function .</brief_summary>
	<brief_title>Comparison Alogliptin Versus Alogliptin Pioglitazone Insulin Resistance Metformin Treated Women With PCOS</brief_title>
	<detailed_description />
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Alogliptin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>18 year old menopause polycystic ovary syndrome ( NICHD criterion ) BMI 30 kg/mÂ² high type 1 type 2 diabetes mellitus history carcinoma Cushing 's syndrome congenital ( nonclassic ) adrenal hyperplasia personal family history MEN 2 significant cardiovascular , kidney hepatic disease</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>